IL27 and myeloid sarcoma: Importantly, the expression of IL-27 and its receptor has been detected in the CSF and post-mortem brain tissues of MS patients [161,162]; additionally, several studies have shown that IL-27 dampens inflammation and disease severity in EAE [38,154,156,163].